{"id":89643,"date":"2019-04-17T13:03:17","date_gmt":"2019-04-17T20:03:17","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/04\/crispr-has-been-used-to-treat-us-cancer-patients-for-the-first-time"},"modified":"2019-04-17T13:03:17","modified_gmt":"2019-04-17T20:03:17","slug":"crispr-has-been-used-to-treat-us-cancer-patients-for-the-first-time","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/04\/crispr-has-been-used-to-treat-us-cancer-patients-for-the-first-time","title":{"rendered":"CRISPR has been used to treat US cancer patients for the first time"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/crispr-has-been-used-to-treat-us-cancer-patients-for-the-first-time2.jpg\"><\/a><\/p>\n<p>The gene-editing tool has been used in a trial to enhance the blood cells of two patients with cancer.<\/p>\n<p><strong>The trial:<\/strong> The experimental research, under way at the University of Pennsylvania, involves genetically altering a person\u2019s T cells so that they attack and destroy cancer. A university spokesman confirmed it has treated the first patients, one with sarcoma and one with multiple myeloma.<\/p>\n<p><strong>Slow start:<\/strong> Plans for the pioneering study were <a href=\"https:\/\/www.technologyreview.com\/s\/601717\/first-human-test-of-crispr-proposed\/\">first reported in 2016<\/a>, but it was slow to get started. Chinese hospitals, meanwhile, have launched a score of similar efforts. Carl June, the famed University of Pennsylvania cancer doctor, has compared the Chinese lead in employing CRISPR to a genetic Sputnik.<\/p>\n<p><a href=\"https:\/\/www.technologyreview.com\/the-download\/613321\/crispr-has-been-used-to-treat-us-cancer-patients-for-the-first-time\/\" target=\"_blank\" rel=\"noopener noreferrer\"><\/p>\n<div style=\"clear:both;\">Read more<\/div>\n<p><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The gene-editing tool has been used in a trial to enhance the blood cells of two patients with cancer. The trial: The experimental research, under way at the University of Pennsylvania, involves genetically altering a person\u2019s T cells so that they attack and destroy cancer. A university spokesman confirmed it has treated the first patients, [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412],"tags":[],"class_list":["post-89643","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/89643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=89643"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/89643\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=89643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=89643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=89643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}